1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals

Renal problems in SLE.
Orateur invité à la réunion du "Groupe Interdisciplinaire des maladies systémiques",
Bruxelles, le 08 janvier 2004
106. D. ABRAMOWICZ
Les traitements anti-rejet de la greffe rénale
Orateur invité à la réunion anatomo-clinique du Centre Hospitalier Universitaire de
Liège
Liège, 03 Février 2004
107. HADAYA K, WISSING M, BROEDERS N, SURQUIN M, ABRAMOWICZ D
Nephrotic-range proteinuria and other severe adverse events after conversion to
sirolimus in renal transplant recipients: is high exposure to sirolimus responsible?
Meeting of the Belgian Transplantation Society, Brussels, March 2004
108. BROEDERS N, HAZZAN M, WISSING M, NOEL C, MASCART F,
ABRAMOWICZ D.
Reduced plasma levels of immunoglobulins and mannose-binding-protein after renal
transplantation under MMF therapy: a longitudinal study.
Meeting of the Belgian Transplantation Society, Brussels, March 2004
109. MBABA MENA, J, N. BROEDERS, M. WISSING, W. WIJNS, O. PRADIER, M.
ABRAMOWICZ, K. HADAYA, M. SURQUIN, N. BEN BOUCHTA,
D. ABRAMOWICZ
A prospective study of the impact of thrombophila on acute rejection and
thromboembolic events after renal transplantation.
Meeting of the Belgian Transplantation Society, Brussels, March 2004
110. ABRAMOWICZ D, GAFNER N, WIJNGAARD P
Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive
regimen: results of a five-year, prospective, randomised study
Meeting of the Belgian Transplantation Society, Brussels, March 2004
111. WISSING M, FOMEGNE G, BROEDERS N, GHISDAL L, HOANG AD,
VEREERSTRAETEN P, ABRAMOWICZ D.
HLA B and DR mismatches remain significant risk factors for acute rejection of kidney
allografts in patients receiving anti-IL2 receptor antibodies, calcineurin inhibitors and
mycophenolate mofetil.
Meeting of the Belgian Transplantation Society, Brussels, April 2006
112. MIKHALSKI D, HOANG AD, ABRAMOWICZ D, DONCKIER V, BOLLENS R.
74